Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing

November 12, 2024/in Corporate News, News, NewsRoom/by chi9iua

Chime Biologics Bridges Innovation and Collaboration at Europe-China Biotech Business Forum 2024

November 4, 2024/in News, NewsRoom, Uncategorized/by chi9iua

Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing

October 28, 2024/in Corporate News, News, NewsRoom/by chi9iua

Chime Biologics congratulates Hope Medicine on HMI-115's CDE Breakthrough Therapy Designation

October 24, 2024/in Corporate News, News/by chi9iua

Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics

October 9, 2024/in News, NewsRoom/by chi9iua

Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborations in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics of bispecific T-cell engagers (TCEs) and antibody-drug conjugates […]